Drugs / SAR228810
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01485302 | Jan 2012 → Feb 2015 | Alzheimer disease | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR228810 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01485302 ↗ |
| Route | Intravenous | “Route of administration: intravenous” NCT01485302 ↗ |